|
|
|
Insider
Information: |
Tang Capital Partners Lp |
Relationship: |
10% Owner |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
123,746 |
|
Indirect Shares
|
35,438,120 |
|
|
Direct
Value |
$25,042 |
|
|
Indirect Value
|
$71,622,161 |
|
|
Total
Shares |
35,561,866 |
|
|
Total
Value |
$71,647,202 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
1
|
Stock
price went up :
|
3
|
0
|
Stock
price went down : |
11
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-4.3%
|
-74.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ardea Biosciences Inc |
RDEA |
10% Owner |
2012-02-01 |
15,089 |
2012-02-01 |
3,800,634 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
2018-09-12 |
6,941 |
2018-09-12 |
5,844,562 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
2008-02-15 |
0 |
2008-02-19 |
25,953 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
2008-11-18 |
27,000 |
2008-11-18 |
3,706,926 |
Premium* |
|
Neose Technologies Inc |
NTEC |
10% Owner |
|
0 |
2008-09-30 |
10,412,306 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2008-08-29 |
4,716 |
2008-09-29 |
785,920 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
|
0 |
2010-01-14 |
2,715,852 |
Premium* |
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-21 |
70,000 |
2008-10-21 |
5,877,000 |
Premium* |
|
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2009-01-09 |
0 |
2010-09-20 |
0 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
|
|
0 |
2014-07-23 |
1,699,067 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2017-02-23 |
559,900 |
Premium* |
|
Aptevo Therapeutics Inc. |
APVO |
Exit Filing |
2020-11-04 |
0 |
2021-11-23 |
0 |
Premium* |
|
Jounce Therapeutics Inc |
JNCE |
10% Owner |
2023-03-13 |
0 |
2023-05-03 |
10,000 |
Premium* |
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2023-05-03 |
0 |
2023-06-01 |
0 |
Premium* |
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2023-05-30 |
0 |
2024-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-05-02 |
4 |
B |
$1.83 |
$183,000 |
I/I |
100,000 |
4,532,038 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-05-07 |
4 |
B |
$1.83 |
$183,160 |
I/I |
100,000 |
4,632,038 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2008-09-22 |
4 |
B |
$1.00 |
$99,880 |
I/I |
100,000 |
4,939,058 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2010-01-04 |
4 |
S |
$11.65 |
$1,165,320 |
I/I |
(100,000) |
2,965,852 |
0 |
- |
|
NTEC |
Neose Technologies Inc |
10% Owner |
|
2008-09-22 |
4 |
B |
$0.32 |
$31,603 |
I/I |
100,200 |
10,251,914 |
1.5 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-04 |
4 |
B |
$1.86 |
$193,888 |
I/I |
104,241 |
4,049,041 |
1.5 |
% |
|
RAIN |
Rain Therapeutics Inc. |
10% Owner |
|
2023-12-15 |
4 |
S |
$1.20 |
$131,322 |
I/I |
(109,435) |
3,890,645 |
0 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2015-05-29 |
4 |
B |
$19.74 |
$2,274,058 |
I/I |
115,225 |
4,711,543 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-03 |
4 |
B |
$1.82 |
$218,532 |
I/I |
120,000 |
3,115,400 |
1.5 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2015-06-10 |
4 |
B |
$24.75 |
$2,999,997 |
I/I |
121,212 |
4,867,530 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-15 |
4 |
B |
$1.77 |
$223,657 |
I/I |
126,438 |
3,597,738 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2009-12-04 |
5 |
GD |
$0.00 |
$0 |
I/I |
129,242 |
67,052 |
0 |
- |
|
RAIN |
Rain Therapeutics Inc. |
10% Owner |
|
2023-10-13 |
4 |
B |
$0.99 |
$130,315 |
I/I |
131,631 |
4,024,486 |
1.5 |
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
|
2017-02-23 |
4 |
B |
$4.34 |
$582,079 |
I/I |
134,200 |
559,900 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2008-11-20 |
4 |
B |
$0.73 |
$105,531 |
I/I |
145,000 |
3,665,852 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-12-17 |
4 |
B |
$11.14 |
$1,745,103 |
I/I |
156,652 |
3,320,112 |
1.5 |
- |
|
RAIN |
Rain Therapeutics Inc. |
10% Owner |
|
2023-05-31 |
4 |
B |
$1.08 |
$179,574 |
I/I |
166,180 |
3,407,016 |
1.5 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-05 |
4 |
B |
$1.90 |
$319,806 |
I/I |
166,823 |
4,215,864 |
1.5 |
% |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-24 |
4 |
B |
$1.81 |
$307,598 |
I/I |
170,000 |
3,972,038 |
1.5 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
10% Owner |
|
2020-11-06 |
4 |
B |
$20.63 |
$3,961,898 |
I/I |
174,277 |
1,760,000 |
1.5 |
% |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2008-12-31 |
4 |
B |
$0.42 |
$72,625 |
I/I |
175,000 |
7,993,325 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-25 |
4 |
B |
$1.77 |
$330,975 |
I/I |
185,000 |
4,157,038 |
1.5 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2018-03-29 |
4 |
B |
$26.00 |
$5,000,008 |
I/I |
192,308 |
8,525,215 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-06-21 |
4 |
B |
$3.57 |
$714,000 |
I/I |
200,000 |
1,003,355 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-29 |
4 |
B |
$1.81 |
$361,360 |
I/I |
200,000 |
4,382,038 |
1.5 |
- |
|
176 Records found
|
|
Page 5 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|